Form 8-K - Current report:
SEC Accession No. 0001641172-25-001698
Filing Date
2025-03-31
Accepted
2025-03-31 16:05:36
Documents
15
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35547
2 ex99-1.htm EX-99.1 97875
3 ex99-1_001.jpg GRAPHIC 5007
  Complete submission text file 0001641172-25-001698.txt   326368

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE celc-20250331.xsd EX-101.SCH 3015
5 XBRL LABEL FILE celc-20250331_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE celc-20250331_pre.xml EX-101.PRE 24165
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3577
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 25793156
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)